← Back to Search

Nonsteroidal Anti-inflammatory Drug

Liquid ASA for Coronavirus (OLA COVID Trial)

Phase 2

Waitlist Available

Research Sponsored by Louisiana State University Health Sciences Center in New Orleans

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

OLA COVID Trial Summary

This trial is testing whether a new, liquid form of aspirin can help with a blood clotting problem seen in some people with COVID-19, which can lead to serious complications.

Eligible Conditions

Coronavirus

OLA COVID Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Reduced COVID-19 related hospitalizations

OLA COVID Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Liquid ASAActive Control1 Intervention

Aspirin 150 mg liquid formulation (2.5%w/w) taken once daily by mouth for 30 days

Group II: PlaceboPlacebo Group1 Intervention

Soy Bean Oil identical packaging as the active arm, taken once daily by mouth for 30 days.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Louisiana State University Health Sciences Center in New OrleansLead Sponsor

114 Previous Clinical Trials

44,001 Total Patients Enrolled

Innovate Anti-InfectivesUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What medical condition is Liquid ASA typically utilized to treat?

"Liquid ASA is commonly employed to treat percutaneous coronary intervention (pci), however, it has also been used in dental procedures, reducing inflammation and relieving pain in the neck."

Answered by AI

Is Liquid ASA approved by the U.S. Food and Drug Administration?

"Due to the lack of clinical evidence in regards to Liquid ASA's efficacy, it was assigned a safety score of 2 on our scale. This is because this trial is only at Phase 2, and thus there has been some data indicating its safety but not backing up its effectiveness yet."

Answered by AI

Are there any remaining vacancies for participants in this clinical trial?

"As per clinicaltrials.gov, this experiment is still in the process of acquiring participants. The study was initially posted on December 6th 2021 and has most recently been updated by investigators on December 13th 2021."

Answered by AI

Is this the maiden investigation of its type?

"The initial clinical trial for Liquid ASA was conducted in 2005, backed by Abbott and involving 15480 participants. This study resulted in Phase 4 drug approval being granted to the medication. Nowadays, 168 active trails are ongoing concerning this drug all over the world, spanning 1398 cities across 57 nations."

Answered by AI

How many participants have enrolled in this research endeavor thus far?

"Affirmative. Clinicaltrials.gov confirms that this medical study, which was initialized on December 6th 2021, is still recruiting patients. About 200 participants need to be sited within a single healthcare institution."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Outpatient Liquid Aspirin (OLA)

2021. "Outpatient Liquid Aspirin (OLA)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04937088.